Literature DB >> 32559570

Efficacy and safety of rIX-FP in surgery: An update from a phase 3b extension study.

Brigitte Pan-Petesch1, Azusa Nagao2, Faraizah Abdul Karim3, Alberto Tosetto4, Maria Teresa Alvarez Roman5, Wilfried Seifert6, Yanyan Li7, Claude Négrier8.   

Abstract

Keywords:  Albumin fusion; Factor IX; Hemophilia B; Surgery; rIX-FP

Mesh：

Substances：

Year:  2020        PMID： 32559570     DOI： 10.1016/j.thromres.2020.05.046

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  2 in total

Review 1.  How do we optimally utilize factor concentrates in persons with hemophilia?

Authors:  Ming Y Lim
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 2.  IDELVION: A Comprehensive Review of Clinical Trial and Real-World Data.

Authors:  Miguel Escobar; Maria Elisa Mancuso; Cedric Hermans; Cindy Leissinger; Wilfried Seifert; Yanyan Li; William McKeand; Johannes Oldenburg
Journal:  J Clin Med       Date:  2022-02-18       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.